Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ascoli Piceno
Clinical trial register · Italy

Clinical Trials in Ascoli Piceno, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto5 Fondazione Italiana Linfomi - ETS4 Marche Region Regional Health Agency2 Regeneron Pharmaceuticals2 Novartis Pharmaceuticals1
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Ascoli Piceno

24 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Marche Region Regional Health Agency
Observational
2,951
Ascoli Piceno, San Benedetto del Tronto
2026-04-09
Recruiting
European Myeloma Network B.V.
Phase 2
150
Ascoli Piceno, Bari, Bergamo, Bologna, Bolzano, Como, Milan, Novara
2025-12-12
Recruiting
Marche Region Regional Health Agency
Not applicable
388
Ancona, Fabriano, Iesi, Ascoli Piceno, San Benedetto del Tronto, Fermo, Civitanova Marche, Province of Macerata
2025-10-13
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Bologna, Ravenna, Trieste, Brescia, Ascoli Piceno, Perugia
2025-09-26
Recruiting
Quovadis Associazione
Observational
120
Marcianise, Mercogliano, Sessa Aurunca, Bologna, Anzio, Milan, Cefalù, Ascoli Piceno
2025-07-10
Recruiting
Study on Plasmablastic Lymphoma Patients
NCT06781359Plasmablastic Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
200
Aviano, Ascoli Piceno, Brescia, Cuneo, Florence, Milan, Monza, Novara
2025-02-14
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
212
Alessandria, Ancona, Ascoli Piceno, Bari, Biella, Bologna, Bolzano, Ferrara
2024-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Meldola, Genoa, Milan, Alessandria, Ascoli Piceno, Pavia, Ravenna
2024-09-16
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Meldola, Tricase, Genoa, Candiolo, Ascoli Piceno, Bologna, Brescia, Milan
2023-12-12
Recruiting
Iperboreal Pharma Srl
Phase 3
170
Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan
2022-12-14
Recruiting
Priothera SAS
Phase 3
366
Brindisi, Reggio Calabria, San Giovanni Rotondo, Lecce, Roma, Alessandria, Ascoli Piceno, Florence
2022-06-16
Active, closed
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
NCT04722848Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL
DrugsPonatinib·Imatinib·Blinatumomab
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
236
Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Mestre, Modena, Pagani
2021-09-08
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Ascoli Piceno, Avellino, Florence, Milan, Roma, Torino, Bassano del Grappa
2021-07-27
Active, closed
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
NCT05027984Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus
Not applicable
1,425
Ascoli Piceno, Acquaviva delle Fonti, Bari, Bergamo, Benevento, Bologna, Cagliari, Aversa
2021-06-30
Active, closed
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
NCT04475731Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
67
Ancona, Ascoli Piceno, Avellino, Bari, Bergamo, Bologna, Brescia, Cuneo
2021-05-04
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
430
Brescia, Piacenza, Rionero in Vulture, Alessandria, Ancona, Ascoli Piceno, Aviano, Barletta
2021-03-23
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Acquaviva delle Fonti, Agrigento, Ancona, Anzio, Ariccia, Ascoli Piceno, Avellino, Avezzano
2021-01-15
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
274
Alessandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto
2020-11-27
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
414
Alessandria, Ancona, Ascoli Piceno, Avellino, Bari, Bologna, Caserta, Castelfranco Veneto
2020-09-24
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
100
Brescia, San Giovanni Rotondo, Tricase, Monza, Ancona, Ascoli Piceno, Bari, Bologna
2019-12-09
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
76
Ancona, Ascoli Piceno, Bergamo, Bologna, Bolzano, Brescia, Cuneo, Genova
2019-10-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Ascoli Piceno, Brescia, Catania, Florence, Milan, Monza, Novara, Roma
2019-08-15
Active, closed
Fondazione EMN Italy Onlus
Phase 3
84
Alessandria, Ancona, Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Cagliari
2019-07-01
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 3
128
Milan, Ravenna, Candiolo, Castelfranco Veneto, Terni, Busto Arsizio, Alessandria, Ascoli Piceno
2014-05
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/ascoli-piceno

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies with a site in Ascoli Piceno.

How many clinical trials are recruiting in Ascoli Piceno?

13 of the 24 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ascoli Piceno), 24 studies
PhaseStudiesRecruitingShare
Phase 311745.8%
Observational5320.8%
Phase 25220.8%
Not applicable218.3%
Phase 2/3104.2%

Most active sponsors

Lead sponsors with the most studies (Ascoli Piceno)
Lead sponsorStudiesRecruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto52
Fondazione Italiana Linfomi - ETS42
Marche Region Regional Health Agency22
Regeneron Pharmaceuticals22
Centro per la Lotta Contro l'Infarto - Fondazione Onlus10
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company10
European Myeloma Network B.V.11
Fondazione EMN Italy Onlus10
Gruppo Italiano Trapianto di Midollo Osseo10
Iperboreal Pharma Srl11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.